Your browser doesn't support javascript.
loading
Label-free enrichment of human pluripotent stem cell-derived early retinal progenitor cells for cell-based regenerative therapies.
Iwama, Yasuaki; Nomaru, Hiroko; Masuda, Tomohiro; Kawamura, Yoko; Matsumura, Michiru; Murata, Yuri; Teranishi, Kazuki; Nishida, Kohji; Ota, Sadao; Mandai, Michiko; Takahashi, Masayo.
Afiliação
  • Iwama Y; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan; Cell and Gene Therapy in Ophthalmology Laboratory, BZP, RIKEN, Wako, Saitama 351-0198, Japan; Department
  • Nomaru H; ThinkCyte K.K., Tokyo 113-8654, Japan.
  • Masuda T; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan; Cell and Gene Therapy in Ophthalmology Laboratory, BZP, RIKEN, Wako, Saitama 351-0198, Japan. Electronic
  • Kawamura Y; ThinkCyte K.K., Tokyo 113-8654, Japan. Electronic address: yoko@thinkcyte.com.
  • Matsumura M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
  • Murata Y; ThinkCyte K.K., Tokyo 113-8654, Japan.
  • Teranishi K; ThinkCyte K.K., Tokyo 113-8654, Japan.
  • Nishida K; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Ota S; ThinkCyte K.K., Tokyo 113-8654, Japan; Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, Japan.
  • Mandai M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan. Electronic address: e_lab.mandai@kcho.jp.
  • Takahashi M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Stem Cell Reports ; 19(2): 254-269, 2024 Feb 13.
Article em En | MEDLINE | ID: mdl-38181785
ABSTRACT
Pluripotent stem cell-based therapy for retinal degenerative diseases is a promising approach to restoring visual function. A clinical study using retinal organoid (RO) sheets was recently conducted in patients with retinitis pigmentosa. However, the graft preparation currently requires advanced skills to identify and excise suitable segments from the transplantable area of the limited number of suitable ROs. This remains a challenge for consistent clinical implementations. Herein, we enabled the enrichment of wild-type (non-reporter) retinal progenitor cells (RPCs) from dissociated ROs using a label-free ghost cytometry (LF-GC)-based sorting system, where a machine-based classifier was trained in advance with another RPC reporter line. The sorted cells reproducibly formed retinal spheroids large enough for transplantation and developed mature photoreceptors in the retinal degeneration rats. This method of enriching early RPCs with no specific surface antigens and without any reporters or chemical labeling is promising for robust preparation of graft tissues during cell-based therapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Retinose Pigmentar / Células-Tronco Pluripotentes Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Retinose Pigmentar / Células-Tronco Pluripotentes Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article